USA prevention country HIV USA

New deal gives hope for injectable PrEP in SA

Reading now: 517
mambaonline.com

As the World Health Organisation (WHO) calls for the use of long-acting injectable PrEP for HIV prevention, a new deal with its manufacturer gives hope that it could be rolled out around the world. PrEP is a highly effective method of HIV prevention, but until recently was only available in pill form, taken daily or, in some cases, before and after sex.

Produced by ViiV Healthcare, Cabotegravir LA (CAB-LA) for PrEP is an important advancement as it can provide two months of highly effective continuous protection against HIV infection through a single injection.

On Thursday, the WHO released new guidelines for the use of CAB-LA as PrEP for HIV and called for countries to consider this a safe and highly effective prevention option for people at higher risk of HIV infection such as gay, bi and other men who have sex with men.

Injectable PrEP makes the use of PrEP easier and more effective as it no longer requires users to remember to take a daily pill, which could result in pill fatigue.

Read more on mambaonline.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA